ACR lung cancer registry receives CMS approval

The American College of Radiology (ACR) Lung Cancer Screening Registry has become the first such registry approved by the Centers for Medicare & Medicaid Services.

With the approval, providers can now submit data on lung cancer screenings to the registry, a requirement to receive reimbursement from Medicare.

“The ACR Lung Cancer Screening Registry is ready to help providers quickly and efficiently meet Medicare reporting requirements and monitor and demonstrate the quality of CT lung cancer screening in their practice,” said Ella Kazerooni, MD, FACR, chair of the American College of Radiology Lung Cancer Screening Committee and ACR Thoracic Imaging Panel, in a statement. “The ACR registry will also compile quality information that can help improve and refine lung cancer screening care over time at the national level.”

The ACR added that its new registry is part of the ACR National Radiology Data Registry that CMS has recognized for the Physician Quality Reporting System.

On Feb. 5, CMS officially approved Medicare coverage of low-dose CT lung cancer screening for high risk patients.

Evan Godt
Evan Godt, Writer

Evan joined TriMed in 2011, writing primarily for Health Imaging. Prior to diving into medical journalism, Evan worked for the Nine Network of Public Media in St. Louis. He also has worked in public relations and education. Evan studied journalism at the University of Missouri, with an emphasis on broadcast media.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.